Modulation of pain, nociception, and analgesia by the brain reward center

Por Mitsi, Vasiliki, Zachariou, Venetia
Publicado no Neuroscience (2016)

Nociception and pain: lessons from optogenetics

Por Carr, Fiona B., Zachariou, Venetia
Publicado em 2014

Opioid–galanin receptor heteromers differentiate the dopaminergic effects of morphine and methadone

Por Serafini, Randal A., Zachariou, Venetia
Publicado no J Clin Invest (2019)

Rodent models of treatment-resistant depression

Por Caldarone, Barbara J., Zachariou, Venetia, King, Sarah L
Publicado no Eur J Pharmacol (2014)

The Mesolimbic Dopamine System in Chronic Pain and Associated Affective Comorbidities

Por Serafini, Randal A., Pryce, Kerri D., Zachariou, Venetia
Publicado no Biol Psychiatry (2020)

Regulation of Gene Expression by Chronic Morphine and Morphine Withdrawal in the Locus Ceruleus and Ventral Tegmental Area

Por McClung, Colleen A., Nestler, Eric J., Zachariou, Venetia
Publicado no J Neurosci (2005)

RGS9-2: probing an intracellular modulator of behavior as a drug target

Por Traynor, John R., Terzi, Dimitra, Caldarone, Barbara J., Zachariou, Venetia
Publicado em 2009

Modulation of opioid receptor function by protein-protein interactions

Por Alfaras-Melainis, Konstantinos, Gomes, Ivone, Rozenfeld, Raphael, Zachariou, Venetia, Devi, Lakshmi
Publicado em 2009

R7BP Modulates Opiate Analgesia and Tolerance but not Withdrawal

Por Terzi, Dimitra, Cao, Yan, Agrimaki, Ioanna, Martemyanov, Kirill A, Zachariou, Venetia
Publicado em 2012

Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research

Por Yiannopoulou, Konstantina G., Anastasiou, Aikaterini I., Zachariou, Venetia, Pelidou, Sygkliti-Henrietta
Publicado no Biomedicines (2019)

Epigenetic Mechanisms of Chronic Pain

Por Descalzi, Giannina, Ikegami, Daigo, Ushijima, Toshikazu, Nestler, Eric, Zachariou, Venetia, Narita, Minoru
Publicado no Trends Neurosci (2015)

RGS9-2 modulates sensory and mood related symptoms of neuropathic pain

Por Terzi, Dimitra, Gaspari, Sevasti, Manouras, Lefteris, Descalzi, Giannina, Mitsi, Vassiliki, Zachariou, Venetia
Publicado no Neurobiol Learn Mem (2014)

GalR1, but not GalR2 or GalR3, levels are regulated by galanin signaling in the locus coeruleus through a cyclic AMP-dependent mechanism

Por Hawes, Jessica J., Brunzell, Darlene H., Wynick, David, Zachariou, Venetia, Picciotto, Marina R.
Publicado em 2005

RGS9-2 modulates nociceptive behaviour and opioid-mediated synaptic transmission in the spinal dorsal horn

Por Papachatzaki, Maria Martha, Antal, Zsófia, Terzi, Dimitra, Szücs, Péter, Zachariou, Venetia, Antal, Miklós
Publicado em 2011

A Unique Role of RGS9-2 in the Striatum as a Positive or Negative Regulator of Opiate Analgesia

Por Psigfogeorgou, Kassi, Terzi, Dimitra, Papachatzaki, Maria Martha, Varidaki, Artemis, Ferguson, Deveroux, Gold, Stephen J., Zachariou, Venetia
Publicado em 2011

Effect of ΔFosB Overexpression on Opioid and Cannabinoid Receptor-Mediated Signaling in the Nucleus Accumbens

Por Sim-Selley, Laura J., Cassidy, Michael P., Sparta, Antonino, Zachariou, Venetia, Nestler, Eric J., Selley, Dana E.
Publicado em 2011

RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States

Por Gaspari, Sevasti, Cogliani, Valeria, Manouras, Lefteris, Anderson, Ethan M, Mitsi, Vasiliki, Avrampou, Kleopatra, Carr, Fiona B, Zachariou, Venetia
Publicado no Neuropsychopharmacology (2017)

Neuropathic pain promotes gene expression adaptations in brain networks involved in stress and depression

Por Descalzi, Giannina, Mitsi, Vasiliki, Purushothaman, Immanuel, Gaspari, Sevasti, Avrampou, Kleopatra, Loh, Yong-Hwee Eddie, Shen, Li, Zachariou, Venetia
Publicado no Sci Signal (2017)

Effective Attenuation of Adenosine A1R Signaling by Neurabin Requires Oligomerization of Neurabin

Por Chen, Yunjia, Booth, Christopher, Wang, Hongxia, Wang, Raymond X., Terzi, Dimitra, Zachariou, Venetia, Jiao, Kai, Zhang, Jin, Wang, Qin
Publicado no Mol Pharmacol (2017)

Galanin negatively modulates opiate withdrawal via galanin receptor 1

Por Holmes, Fiona E., Armenaki, Athena, Iismaa, Tiina P., Einstein, Emily B., Shine, John, Picciotto, Marina R., Wynick, David, Zachariou, Venetia
Publicado em 2011